S&P cuts its outlook for Turkey’s long-term foreign credit ratings
TİM President Mehmet Büyükekşı announces the April export figures at a press meeting in Balıkesir today.Turkish exports in April fell
Read More
Business Sectors
Minister Yıldırım says Canal Istanbul to be real in six years
A tanker assisted by pilot ships passes through Istanbul’s Bosphorus. Minister Binali Yıldırım says a canal project will cut the
Read More
Turkey’s tourism revenues drop by 9.7 percent in first quarter 2012
Turkey’s tourism revenues down by 9.7 pct in Q1 Turkey’s tourism revenues dropped by 9.7 percent in the first three
Read More
Sanofi to relocate its regional center from Dubai to ıstanbul
Turkey’s Istanbul has become home to yet another multinational company’s regional management center, this time to French pharmaceutical company, Sanofi.
Read More
UK Minister: Turkey best location to invest for mid-sized British firms
A trade mission to Turkey by a British delegation underscored the country’s unique status as a favorable investment location and
Read More
EBRD signs new deal with Sabancı & Enerjisa for wind energy
The European Bank for Reconstruction and Development, which has lent 1.6 billion euros to Turkey, has just signed a new
Read More
PM Erdoğan expects to see more Arab tourists in Turkey
Prime Minister Recep Tayyip Erdoğan has invited Arab tourists to Turkey to enjoy all four seasons and 365 days of
Read More
Kafkas branded “Kestane Şekeri” (candied chestnuts) from Bursa
Kestane Şekeri (Candied chestnuts) is a popular delicacy of Bursa one of the greenest and most beautiful and historical cities
Read More
Points to Consider When Importing Natural Stone from Turkey
Natural stone industry in Turkey – Anatolian (Minor Asia) soil has a rich blend of natural stones such as marble,
Read More
Turkish state-run oil company to start drilling in North Cyprus
Turkey’s state-run oil company is set to start drilling for oil and gas in the Turkish Republic of Northern Cyprus
Read More
U.S. drugs giant Amgen buys out Mustafa Nevzat for $700 million.
U.S. drugs giant Amgen has announced that it has agreed to buy out Turkish Mustafa Nevzat for $700 million. Amgen
Read More